Methods
IDLV expressing Flu-M1 containing simian immunodeficiency virus (SIV)-Vpx was produced and titred on 293T by standard methods. Monocytes from HLA-A*0201 and M1-positive selected donors were differentiated into DC and transduced with IDLV-M1/Vpx and control IDLV/M1 or left untreated. IDLV-transduced DC were co-cultured with autologous PBMC and the expansion of M1-specific CD8+ T cells was analysed by pentamer staining and IFNγ ELISPOT
Results
The addition of the SIV-Vpx protein during IDLV preparation resulted in a striking improvement of IDLV transduction of human DC, thus increasing the ability of IDLV-transduced DC to act as functional antigen presenting cells, as evaluated by pentamer staining and IFNγ ELISPOT, in the absence of vector integration. Importantly, the presence of SIV-Vpx allows for the use of lower amount of input vector preparation, further improving the safety profile of IDLV.
Conclusion
These results have important implications for the development of vaccine strategies based on the use of IDLV as a novel, safe and efficient delivery system. 
